Control of B cell development by Ras-mediated activation of Raf

被引:131
作者
Iritani, BM
Forbush, KA
Farrar, MA
Perlmutter, RM [1 ]
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biochem Med Med Genet, Seattle, WA 98195 USA
[3] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[5] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Rahway, NJ 07065 USA
关键词
B cell development; Raf; Ras; transgenic mice;
D O I
10.1093/emboj/16.23.7019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell fate commitment in a variety of lineages requires signals conveyed via p21(ras). To examine the role of p21(ras) in the development of B lymphocytes, we generated transgenic mice expressing a dominant-negative form of Ras in B lymphocyte progenitors, using a novel transcriptional element consisting of the E mu enhancer and the lck proximal promoter. Expression of dominant-negative Ras arrests B cell development at a very early stage, prior to formation of the pre-B cell receptor. Furthermore, an activated form of Raf expressed in the same experimental system could both drive the maturation of normal pro-B cells and rescue development of progenitors expressing dominant-negative Ras. Hence p21(ras) normally regulates early development of B lymphocytes by a mechanism that involves activation of the serine/threonine kinase Raf.
引用
收藏
页码:7019 / 7031
页数:13
相关论文
共 106 条
[1]   GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN (GAP) INTERACTS WITH THE P21-RAS EFFECTOR BINDING DOMAIN [J].
ADARI, H ;
LOWY, DR ;
WILLUMSEN, BM ;
DER, CJ ;
MCCORMICK, F .
SCIENCE, 1988, 240 (4851) :518-520
[2]   Positive and negative selection invoke distinct signaling pathways [J].
AlberolaIla, J ;
Hogquist, KA ;
Swan, KA ;
Bevan, MJ ;
Perlmutter, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :9-18
[3]   SELECTIVE REQUIREMENT FOR MAP KINASE ACTIVATION IN THYMOCYTE DIFFERENTIATION [J].
ALBEROLAILA, J ;
FORBUSH, KA ;
SEGER, R ;
KREBS, EG ;
PERLMUTTER, RM .
NATURE, 1995, 373 (6515) :620-623
[4]   EXPRESSION OF THE C-MYC ONCOGENE UNDER CONTROL OF AN IMMUNOGLOBULIN ENHANCER IN E-MU-MYC TRANSGENIC MICE [J].
ALEXANDER, WS ;
SCHRADER, JW ;
ADAMS, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (04) :1436-1444
[5]   FUNCTIONAL DISSECTION OF THE LCK PROXIMAL PROMOTER [J].
ALLEN, JM ;
FORBUSH, KA ;
PERLMUTTER, RM .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2758-2768
[6]   INVOLVEMENT OF P59FYN(T) IN INTERLEUKIN-5 RECEPTOR SIGNALING [J].
APPLEBY, MW ;
KERNER, JD ;
CHIEN, S ;
MALISZEWSKI, CR ;
BONDADAA, S ;
PERLMUTTER, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :811-820
[7]   E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS [J].
BAIN, G ;
MAANDAG, ECR ;
IZON, DJ ;
AMSEN, D ;
KRUISBEEK, AM ;
WEINTRAUB, BC ;
KROP, I ;
SCHLISSEL, MS ;
FEENEY, AJ ;
VANROON, M ;
VANDERVALK, M ;
TERIELE, HPJ ;
BERNS, A ;
MURRE, C .
CELL, 1994, 79 (05) :885-892
[8]  
BAKER DA, 1994, LEUKEMIA, V8, P1970
[9]  
BALDARI CT, 1993, J BIOL CHEM, V268, P2693
[10]  
BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849